Skip to content

Device to Reduce Surgery Site Contamination

Reduction of Airborne Particulate in the Surgical Field Using Directed Local Airflow

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00972153
Enrollment
29
Registered
2009-09-04
Start date
2009-05-31
Completion date
2009-09-30
Last updated
2012-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

Decrease in CFU density at surgery site, Decrease in airborne particulate at surgery site

Brief summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.

Detailed description

The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the Air Barrier System can reduce the presence of airborne colony-forming units (e.g. bacteria colonies) and particulate at the surgery site.

Interventions

Device is deployed adjacent to the surgery site and activated so that the filtered air emits over the surgery site.

DEVICESham Air Barrier System device

Device is deployed to the surgery site, but the airflow is not activated. This intervention is used to determine any effects that the presence of the device alone may have.

Sponsors

Nimbic Systems, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Candidate for primary total hip arthroplasty

Exclusion criteria

* Prior history of infection * Revision arthroplasty * Screens positive for MRSA * Undergoing hemiarthroplasty or resurfacing

Design outcomes

Primary

MeasureTime frameDescription
Surgery Site CFU DensityTen minute intervals throughout surgeryColony forming unit counts were collected from the air within 5 cm of the surgical wound using a bioaerosol slit sampling device. Air was drawn through a sterile PVC tubing located at the incision and impacted upon media (TSA 5% sheep's blood) plates located in the sampling device. The plates were exchanged every 10 minutes throughout the procedure. Values are presented as CFU/cubic meter.

Secondary

MeasureTime frameDescription
Surgery Site Particulate Density (Size >10 Micrometer)Per Cubic MeterTen minute intervals throughout surgeryAirborne particulate was measured using a particle analyzer (LASAIR II 310B). The analyzer sampled continuously during surgery at a rate of 28.3 L/min and recorded data at one-minute intervals. The samples were collected through a length of sterile PVC tubing with the end placed adjacent to the CFU sample tubing, within 5 cm of the surgical incision. Particles of various diameters were obtained; particles of size \>10 micrometer had the strongest correlation to the presence of CFUs at the incision site.

Countries

United States

Participant flow

Recruitment details

Thirty-six patients of the surgeon who consented to undergo primary total hip arthroplasty between May and September 2009 were recruited to participate in this study. All consenting patients were eligible. Patients undergoing hemiarthroplasty, resurfacing, or revision arthroplasty were excluded from recruitment.

Participants by arm

ArmCount
No Device Used12
Device Attached, Not Activated12
Device Deployed and Activated12
Total36

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyEquipment malfunction during case010

Baseline characteristics

CharacteristicNo Device UsedDevice Attached, Not ActivatedDevice Deployed and ActivatedTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants3 Participants4 Participants11 Participants
Age, Categorical
Between 18 and 65 years
8 Participants9 Participants8 Participants25 Participants
Region of Enrollment
United States
12 participants12 participants12 participants36 participants
Sex: Female, Male
Female
7 Participants6 Participants7 Participants20 Participants
Sex: Female, Male
Male
5 Participants6 Participants5 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Surgery Site CFU Density

Colony forming unit counts were collected from the air within 5 cm of the surgical wound using a bioaerosol slit sampling device. Air was drawn through a sterile PVC tubing located at the incision and impacted upon media (TSA 5% sheep's blood) plates located in the sampling device. The plates were exchanged every 10 minutes throughout the procedure. Values are presented as CFU/cubic meter.

Time frame: Ten minute intervals throughout surgery

Population: Airborne CFU densities were obtained in ten-minute intervals throughout each procedure. Average surgery duration was 69 minutes in the control and sham groups; 66 minutes in the experiment group. A total of 208 density readings were obtained.

ArmMeasureValue (MEDIAN)
No Device UsedSurgery Site CFU Density7 CFU/cubic meter
Device Attached, Not ActivatedSurgery Site CFU Density11 CFU/cubic meter
Device Deployed and ActivatedSurgery Site CFU Density0 CFU/cubic meter
Comparison: Descriptive statistics (means, medians, frequencies) were used to evaluate the distributions of variables. One-way analysis of variance and independent t-tests or Mann-Whitney U tests were used to compare patient and environmental characteristics between groups. Generalized estimating equations were used to evaluate the effects of group and other factors on airborne CFUs/cubic meter at the surgical site in each 10 minute interval.p-value: <0.001t-test, 2 sided
Secondary

Surgery Site Particulate Density (Size >10 Micrometer)Per Cubic Meter

Airborne particulate was measured using a particle analyzer (LASAIR II 310B). The analyzer sampled continuously during surgery at a rate of 28.3 L/min and recorded data at one-minute intervals. The samples were collected through a length of sterile PVC tubing with the end placed adjacent to the CFU sample tubing, within 5 cm of the surgical incision. Particles of various diameters were obtained; particles of size \>10 micrometer had the strongest correlation to the presence of CFUs at the incision site.

Time frame: Ten minute intervals throughout surgery

ArmMeasureValue (MEDIAN)
No Device UsedSurgery Site Particulate Density (Size >10 Micrometer)Per Cubic Meter1377 >10 micrometer particles / cubic meter
Device Attached, Not ActivatedSurgery Site Particulate Density (Size >10 Micrometer)Per Cubic Meter1165 >10 micrometer particles / cubic meter
Device Deployed and ActivatedSurgery Site Particulate Density (Size >10 Micrometer)Per Cubic Meter247 >10 micrometer particles / cubic meter
Comparison: Descriptive statistics (means, medians, frequencies) were used to evaluate the distributions of variables. One-way analysis of variance and independent t-tests or Mann-Whitney U tests were used to compare patient and environmental characteristics between groups. Generalized estimating equations were used to evaluate the effects of group and other factors on airborne CFUs/cubic meter at the surgical site in each 10 minute interval.p-value: <0.001t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026